PHIBRO ANIMAL HEALTH CORP (PAHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue Quarterly

0 150M 300M 450M Q4 '21: 220.3M Q1 '22: 214.7M Q2 '22: 232.7M Q3 '22: 239.6M Q4 '22: 255.3M Q1 '23: 232.5M Q2 '23: 244.6M Q3 '23: 245.7M Q4 '23: 255M Q1 '24: 231.3M Q2 '24: 249.9M Q3 '24: 263.2M Q4 '24: 273.2M Q1 '25: 260.4M Q2 '25: 309.3M Q3 '25: 347.8M Q4 '25: 378.7M Q1 '26: 363.9M Q2 '26: 373.9M Q3 '26: 383.5M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Gross Profit Quarterly

0 50M 100M 150M Q4 '21: 69.8M Q1 '22: 64.7M Q2 '22: 70.7M Q3 '22: 71.6M Q4 '22: 78.4M Q1 '23: 68.6M Q2 '23: 77.4M Q3 '23: 75.5M Q4 '23: 76.7M Q1 '24: 67.7M Q2 '24: 78.6M Q3 '24: 79.6M Q4 '24: 87.2M Q1 '25: 83.5M Q2 '25: 101.9M Q3 '25: 104.6M Q4 '25: 110M Q1 '26: 119.8M Q2 '26: 132.7M Q3 '26: 125.7M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating Income Quarterly

-20M 0 20M 40M 60M Q4 '21: 19.2M Q1 '22: 14.6M Q2 '22: 22.3M Q3 '22: 19.2M Q4 '22: 22.9M Q1 '23: 13.7M Q2 '23: 15.8M Q3 '23: 18.6M Q4 '23: 23.8M Q1 '24: -726K Q2 '24: 15.7M Q3 '24: 19.9M Q4 '24: 18.4M Q1 '25: 17.7M Q2 '25: 25.5M Q3 '25: 33.5M Q4 '25: 33.7M Q1 '26: 51.3M Q2 '26: 50.3M Q3 '26: 44.7M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Net Income Quarterly

-10M 0 10M 20M 30M Q4 '21: 17.1M Q1 '22: 6.5M Q2 '22: 17.5M Q3 '22: 17.7M Q4 '22: 7.5M Q1 '23: 3.9M Q2 '23: 7.2M Q3 '23: 10M Q4 '23: 11.5M Q1 '24: -8M Q2 '24: 1.3M Q3 '24: 8.4M Q4 '24: 752K Q1 '25: 7M Q2 '25: 3.2M Q3 '25: 20.9M Q4 '25: 17.2M Q1 '26: 26.5M Q2 '26: 27.5M Q3 '26: 24M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Cost of Revenue Quarterly

0 100M 200M 300M Q4 '21: 150.4M Q1 '22: 150M Q2 '22: 162M Q3 '22: 168M Q4 '22: 176.8M Q1 '23: 163.9M Q2 '23: 167.3M Q3 '23: 170.1M Q4 '23: 178.4M Q1 '24: 163.6M Q2 '24: 171.3M Q3 '24: 183.6M Q4 '24: 186M Q1 '25: 176.9M Q2 '25: 207.4M Q3 '25: 243.3M Q4 '25: 268.7M Q1 '26: 244.1M Q2 '26: 241.3M Q3 '26: 257.9M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating Cash Flow Quarterly

-15M 0 15M 30M 45M Q4 '21: 3.1M Q1 '22: 3.8M Q2 '22: 20.1M Q3 '22: 6.1M Q4 '22: 1.6M Q1 '23: -10.7M Q2 '23: -2.5M Q3 '23: 6.3M Q4 '23: 20.2M Q1 '24: 16.2M Q2 '24: 31.6M Q3 '24: 11.4M Q4 '24: 28.4M Q1 '25: 12.6M Q2 '25: 3.1M Q3 '25: 43.2M Q4 '25: 21.3M Q1 '26: 9.3M Q2 '26: 19.4M Q3 '26: 16.2M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Free Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q4 '21: -4M Q1 '22: -3.6M Q2 '22: 12.4M Q3 '22: -3.9M Q4 '22: -10.3M Q1 '23: -33.9M Q2 '23: -12.3M Q3 '23: -1.6M Q4 '23: 9.3M Q1 '24: 8.7M Q2 '24: 20.6M Q3 '24: 1.7M Q4 '24: 15.4M Q1 '25: 3M Q2 '25: -4.7M Q3 '25: 35.4M Q4 '25: 8.1M Q1 '26: -4.5M Q2 '26: 8.3M Q3 '26: 890K Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '20: 40.5M Q3 '20: 40.5M Q1 '21: 40.5M Q2 '21: 40.5M Q3 '21: 40.5M Q1 '22: 40.5M Q2 '22: 40.5M Q3 '22: 40.5M Q1 '23: 40.5M Q2 '23: 40.5M Q3 '23: 40.5M Q1 '24: 40.5M Q2 '24: 40.5M Q3 '24: 40.5M Q1 '25: 40.6M Q2 '25: 40.7M Q3 '25: 40.7M Q1 '26: 40.9M Q2 '26: 41M Q3 '26: 41M Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.80 1.60 2.40 Q4 '21: 1.34 Q1 '22: 1.20 Q2 '22: 1.31 Q3 '22: 1.45 Q4 '22: 1.21 Q1 '23: 1.15 Q2 '23: 0.90 Q3 '23: 0.71 Q4 '23: 0.82 Q1 '24: 0.52 Q2 '24: 0.37 Q3 '24: 0.33 Q4 '24: 0.06 Q1 '25: 0.43 Q2 '25: 0.48 Q3 '25: 0.78 Q4 '25: 1.19 Q1 '26: 1.67 Q2 '26: 2.26 Q3 '26: 2.34 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.